Exchange: NASDAQ·Updated 07:40 PM EST

About SLXN

About

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
14

Frequently Asked Questions

Advertisement|Remove ads.